On-demand webinar: Introducing PyroMAT- The Only Cell-line Based MAT Kit Available on the Market
Posted: 28 June 2019 | Merck | No comments yet
Testing for pyrogens is a critical step in ensuring the safety of parenteral pharmaceutical products and medical devices.
The Monocyte Activation Test (MAT) can detect both endotoxin and non-endotoxin pyrogens in one test. Supported by many regulatory bodies, the robust MAT assay produces sensitive results based on the human immune reaction.
Related topics
Endotoxin, Endotoxin Detection, Medical Devices, Regulation & Legislation, Technology
